Pathophysiological advances in membranous nephropathy: Time for a shift in patient's care, Lancet, vol.385, 1983. ,
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy, N Engl J Med, vol.361, pp.11-21, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00417718
Membranous nephropathy: A journey from bench to bedside, Am J Kidney Dis, vol.68, pp.138-147, 2016. ,
Anti-phospholipase A2 receptor antibody titer predicts postrituximab outcome of membranous nephropathy, J Am Soc Nephrol, vol.26, pp.2545-2558, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-02193793
Combined assessment of phospholipase A2 receptor autoantibodies and glomerular deposits in membranous nephropathy, J Am Soc Nephrol, vol.27, pp.3195-3203, 2016. ,
Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy, J Am Soc Nephrol, vol.25, pp.1357-1366, 2014. ,
Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up, J Am Soc Nephrol, vol.28, pp.348-358, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01490466
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy, N Engl J Med, vol.371, pp.2277-2287, 2014. ,
Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy, J Clin Invest, vol.126, pp.2519-2532, 2016. ,
Biomarkers to detect membranous nephropathy in Chinese patients, Oncotarget, vol.7, pp.67868-67879, 2016. ,
PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy, N Engl J Med, vol.364, pp.689-690, 2011. ,
An indirect immunofluorescence method facilitates detection of thrombospondin type 1 domain-containing 7A-specific antibodies in membranous nephropathy, J Am Soc Nephrol, vol.28, pp.520-531, 2017. ,
Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy, Clin Chim Acta, vol.421, pp.213-218, 2013. ,
Prevalence of enhanced granular expression of thrombospondin type-1 domain-containing 7A in the glomeruli of Japanese patients with idiopathic membranous nephropathy, PLoS One, vol.10, p.138841, 2015. ,
THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity, Mod Pathol, vol.29, pp.421-426, 2016. ,
The KDIGO practice guideline on glomerulonephritis: Reading between the (guide)lines-Application to the individual patient, Kidney Int, vol.82, pp.840-856, 2012. ,
An immunofluorescence test for phospholipase-A 2 -receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis, Nephrol Dial Transplant, vol.26, pp.2526-2532, 2011. ,
The clinical and immunological features of patients with combined antiglomerular basement membrane disease and membranous nephropathy, Kidney Int, vol.85, pp.945-952, 2014. ,
MHC class II risk alleles and amino acid residues in idiopathic membranous nephropathy, J Am Soc Nephrol, vol.28, pp.1651-1664, 2017. ,
A mechanism for cancer-associated membranous nephropathy, N Engl J Med, vol.374, 1995. ,
Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy, Am J Nephrol, vol.41, pp.345-353, 2015. ,
Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy, Nephrol Dial Transplant, vol.28, pp.1839-1844, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00919114
Epitope spreading of autoantibody response to PLA2R associates with poor prognosis in membranous nephropathy, J Am Soc Nephrol, vol.27, pp.1517-1533, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01455661
Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease, J Am Soc Nephrol, vol.17, pp.2937-2944, 2006. ,